![Pamela Esposito](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Esposito
Director/Board Member at
KYMERA THERAPEUTICS, INC.
Net worth: 103 400 $ as of 2026-07-30
Profile
Dr. Pamela Esposito is an Independent Director at Kymera Therapeutics, Inc. and an Advisor at Atlas Venture Advisors, Inc. She is on the Board of Directors at Kymera Therapeutics, Inc. and Accent Therapeutics, Inc. Dr. Esposito was previously employed as a Chief Business Officer by Replimune Group, Inc., a Chief Business Officer by RA Pharmaceuticals, Inc., a Head-Corporate Development by Angiochem, Inc., a Vice President-Business Development by BioVex Group, Inc., a Principal by BioDuro LLC, and a Principal by Galenea Corp.
She also served on the board at Vion Pharmaceuticals, Inc. and BioDuro (Beijing) Co., Ltd. She received her undergraduate degree from Dartmouth College and a doctorate degree from Tufts University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-23 | 1,000 ( 0% ) | 103 400 $ | 2026-07-30 |
Pamela Esposito active positions
| Companies | Position | Start |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Director/Board Member | 2020-09-03 |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops treatments for cancer patients | Director/Board Member | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Former positions of Pamela Esposito
| Companies | Position | End |
|---|---|---|
| REPLIMUNE GROUP, INC. | Investor Relations Contact | - |
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2014-12-31 |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Corporate Officer/Principal | 2013-09-29 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Corporate Officer/Principal | 2011-12-30 |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small molecule anticancer compounds | Director/Board Member | 2009-12-30 |
Training of Pamela Esposito
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small molecule anticancer compounds | Health Technology |
Galenea Corp.
 Galenea Corp. Pharmaceuticals: MajorHealth Technology Develop therapeutics and drugs for central nervous system diseases | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
BioDuro LLC
 BioDuro LLC Medical/Nursing ServicesHealth Services Provides drug discovery contract research development and manufacturing services | Health Services |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Health Technology |
BioDuro (Beijing) Co., Ltd.
 BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research and development services | Commercial Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops treatments for cancer patients | Health Technology |
- Stock Market
- Insiders
- Pamela Esposito
